25 research outputs found
An Enhanced Multi-Objective Biogeography-Based Optimization Algorithm for Automatic Detection of Overlapping Communities in a Social Network with Node Attributes
Community detection is one of the most important and interesting issues in
social network analysis. In recent years, simultaneous considering of nodes'
attributes and topological structures of social networks in the process of
community detection has attracted the attentions of many scholars, and this
consideration has been recently used in some community detection methods to
increase their efficiencies and to enhance their performances in finding
meaningful and relevant communities. But the problem is that most of these
methods tend to find non-overlapping communities, while many real-world
networks include communities that often overlap to some extent. In order to
solve this problem, an evolutionary algorithm called MOBBO-OCD, which is based
on multi-objective biogeography-based optimization (BBO), is proposed in this
paper to automatically find overlapping communities in a social network with
node attributes with synchronously considering the density of connections and
the similarity of nodes' attributes in the network. In MOBBO-OCD, an extended
locus-based adjacency representation called OLAR is introduced to encode and
decode overlapping communities. Based on OLAR, a rank-based migration operator
along with a novel two-phase mutation strategy and a new double-point crossover
are used in the evolution process of MOBBO-OCD to effectively lead the
population into the evolution path. In order to assess the performance of
MOBBO-OCD, a new metric called alpha_SAEM is proposed in this paper, which is
able to evaluate the goodness of both overlapping and non-overlapping
partitions with considering the two aspects of node attributes and linkage
structure. Quantitative evaluations reveal that MOBBO-OCD achieves favorable
results which are quite superior to the results of 15 relevant community
detection algorithms in the literature
Effect of Ghrelin on Caspase 3 and Bcl2 Gene Expression in H2O2 Treated Ratās Bone Marrow Stromal Cells
Purpose: The antiapoptotic effect of ghrelin in various cell lines including bone marrow stromal cells (BMSCs) has been proved. However, the real mechanism of this effect is not clear. Caspase3 and Bcl2 are well-known pro- and antiapoptotic regulatory genes in eukaryotes. The aim of the study was to find out the effect of ghrelin on Caspase 3 and Bcl2 change in BMSCs. Methods: Rat BMSCs were cultivated in DMEM. Passage 3 BMSCs were treated with ghrelin 100 Ī¼M for 48 h. Real-time PCR for Caspase 3 and Bcl2 was carried out from B (untreated BMSCs), BH (BMSCs treated with 125 ĀµM H2O2), BGH (BMSCs treated with 100 ĀµM ghrelin then 125 ĀµM H2O2) and BG (BMSCs treated with 100 ĀµM ghrelin) groups. For immunofluorescence, cells were incubated with anti Caspase 3 and Bcl2monoclonal antibodies. Primary antibodies were visualized using the FITC method. All data are presented as means Ā± SEM. Values of P<0.05 were considered statistically significant. Results: Ghrelin decreased mRNA expressions of Caspase-3 significantly as compared to the BH group (P<0.05). Also, Bcl-2 gene expression showed an increment in BG group as compare with BH and BGH groups (P<0.05). A high present of Bcl-2 positive cells were observed in the BGH group while Caspase-3 positive cells were significantly decreased in the BGH group compared with the BH group (P<0.05). Conclusion: Ghrelin probably enhances BMSCs viability through regulation of pro- and antiapoptotic genes Caspase 3 and Bcl2. However the signaling pathway of this effect should be elucidated in the future
Alendronate improves fasting plasma glucose and insulin sensitivity and decreases insulin resistance in prediabetic osteopenic postmenopausal women: a randomized triple-blind clinical trial
Aims
Postmenopausal women receive bisphosphonates for osteoporosis treatment. The effect of these medications on developing diabetes mellitus (DM) in prediabetic patients is yet to be investigated. We aimed to determine the effect of alendronate on plasma glucose, insulin indices of postmenopausal women with prediabetes and osteopenia.
Methods
This tripleāblind randomized controlled clinical trial included 60 postmenopausal women, aged 45ā60 years. All patients were vitamin D sufficient. They were randomly enrolled in intervention (70 mg/week alendronate for 12 week) and control (placebo tablet per week for 12 weeks) groups. The morning 8 hour fasting blood samples were collected at the baseline and followāup visits to measure the fasting plasma glucose (FPG) (mg/dl), insulin and hemoglobin A1c (HbA1c). Plasma glucose and insulin concentration were measured 30, 60, and 120 minutes after glucose tolerance test. Matsuda index, homeostasis model assessment of insulin resistance (HOMAāIR), homeostasis model assessment of betaācell function (HOMAāB) and the area under the curves (AUC) of glucose and insulin were calculated.
Results
Mean (SD) FPG (102.43 (1.46) mg/dl vs. 94.23)1.17) mg/dl, P=0.001), 120āminutes insulin concentration (101.86)15.70) mU/l vs. 72.60 (11.36), P=0.026), HbA1c (5.60 (0.06) % vs. 5.40 (0.05)%, P=0.001), HOMAāIR (3.57 (0.45) vs. 2.62 (0.24), P=0.021) and Matsuda index (7.7 (0.41) vs. 9.2 (0.4), P=0.001) significantly improved in the alendronateātreated group. There was statistically significant more reductions in FPG (ā8.2 (8.63) mg/dl vs. ā2.5 (14.26) mg/dl, P=0.002) and HbA1c (ā0.2 (0.23) % vs. ā0.09 (0.26) %, P=0.015) were observed in alendronateātreated group than placebo group during the study course, respectively.
Conclusions
Administration of 70 mg/week alendronate improves fasting plasma glucose, HbA1c and insulin indices in postmenopausal women
Depression, anxiety and stress, comorbidity evaluation among a large sample of general adults: results from SEPAHAN study
Depression, anxiety and stress are common psychological disorders (PDs). This study aimed to assess the odds of co-occurrence of mentioned PDs in total sample and different levels of socio-demographic characteristics, specifically among a large sample of general adults. In a cross-sectional, community-based study conducted among 4763 Iranian adults, depression and anxiety were assessed with Hospital Anxiety and Depression Scale (HADS) and stress with General Health Questionnaire (GHQ). The loglinear analysis was applied to investigate their comorbidities. Based on selected models with pair-comorbidity of anxiety with stress, depression with stress, and anxiety with depression, the results showed the odds of comorbidity between anxiety and depression (odds ratio (OR) =12.29, 95%CI: 9.58-15.80), depression and stress (OR = 7.80, 95%CI: 6.55-10.18), and stress and anxiety (OR = 4.62, 95%CI: 3.71-5.75). Also, ORs of pair-comorbidities were the same, except between stress and anxiety for men compared to women (adjusted-OR = 6.47, 95%CI: 4.44-9.49 versus 3.85, 95%CI: 2.95-5.00) and comorbidity between stress and depression for the participants with lower than 40 years compared to others (adjusted-OR = 9.03, 95%CI: 7.17-11.36 versus 6.41, 95%CI: 4.90-8.41), p< 0.05. Stress comorbidity with depression was higher level than other pair-comorbidities. Obvious discrepancies were also observed in terms of ORs of pair-comorbidities between three mentioned disorders in different levels of SDCs
Ghrelin Upregulates Hoxb4 Gene Expression in Rat Bone Marrow Stromal Cells
Objective
Ghrelin is a peptide which has a proliferative and antiapoptotic effect in many cells including bone marrow stromal cells (BMSCs). Homeobox protein B4 (HOXB4) is a transcription factor involved in stem cell regeneration and survival. The aim of the study was to find out the effect of ghrelin on Hoxb4 expression in BMSCs.
Materials and Methods
In this experimental study, rat BMSCs were cultivated in Dulbeccoās Modified Eagle Medium (DMEM). Passage three BMSCs were treated with ghrelin 100 Ī¼M for 48 hours. Real-time polymerase chain reaction (PCR) was carried out from the untreated BMSCs (B), BMSCs treated with 125 ĀµM H2O2 (BH), BMSCs treated with 100 ĀµM ghrelin then 125 ĀµM H2O2(BGH) and BMSCs treated with 100 ĀµM ghrelin (BG) groups. For immunofluorescence, cells were incubated with an anti-HOXB4 monoclonal antibody. Primary antibodies were visualized using the Fluorescein isothiocyanate (FITC) method. All data are presented as mean Ā± SEM and P<0.05 was considered as statistical significant.
Results
Hoxb4 expression significantly increased in the BG compared with BH and BGH groups. Furthermore, 100 ĀµM ghrelin, increased the mean of HOXB4 positive immunoreactive cells compared to the BH group.
Conclusion
Ghrelin probably enhances proliferation and viability of BMSCs through Hoxb4 upregulation. However, the signaling pathway and other biological outcomes of this effect should be elucidated in different stem cells
Posterolateral instrumented fusion with and without transforaminal lumbar interbody fusion for the treatment of adult isthmic spondylolisthesis: A randomized clinical trial with 2-year follow-up
Background: Spondylolisthesis is a common cause of surgery in patients with lower back pain. Although posterolateral fusion and pedicle screw fixation are a relatively common treatment method for the treatment of spondylolisthesis, controversy exists about the necessity of adding interbody fusion to posterolateral fusion. The aim of our study was to assess the functional disability, pain, and complications in patients with spondylolisthesis treated by posterolateral instrumented fusion (PLF) with and without transforaminal lumbar interbody fusion (TLIF) in a randomized clinical trial. Materials and Methods: From February 2007 to February 2011, 50 adult patients with spondylolisthesis were randomly assigned to be treated with PLF or PLF+TLIF techniques (25 patients in each group) by a single surgeon. Back pain, leg pain, and disability were assessed before treatment and until 2 years after surgical treatment using visual analog scale (VAS) and oswestry disability index (ODI). Patients were also evaluated for postoperative complications such as infection, neurological complications, and instrument failure. Results: All patients completed the 24 months of follow-up. Twenty patients were females and 30 were males. Average age of the patients was 53 Ā± 11 years for the PLF group and 51 Ā± 13 for the PLF + TLIF group. Back pain, leg pain, and disability score were significantly improved postoperatively compared to preoperative scores (P < 0.001). At 3 months of follow-up, there was no statistically significant difference in VAS score for back pain and leg pain in both groups; however, after 6 months and 1 year and 2 years follow-up, the reported scores for back pain and leg pain were significantly lower in the PLF+TLIF group (P < 0.05). The ODI score was also significantly lower in the PLF+TLIF group at 1 year and 2 years of follow-up (P < 0.05). One screw breakage and one superficial infection occurred in the PLF+TLIF group, which had no statistical significance (P = 0.373). Conclusion: It seems that accompanying TLIF with PLF might lead to better functional improvement and pain reduction in patients with spondylolisthesis
Homeobox B4 gene expression is upregulated by ghrelin through PI3-kinase signaling pathway in ratās bone marrow stromal cells
Objective. Ghrelin, a 28 amino acid peptide, has diverse physiological roles. Phosphatidylino-sitol-bisphosphate 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) are involved in some of the recognized actions of ghrelin. It has been shown that ghrelin upregulates HOXB4 gene expression but the real mechanism of this effect is not clear
Effect of Teucrium polium leaf extracts on AMPK level in Isolated Rat Pancreases
Background: The purpose of this study is to evaluate effects of Teucrium polium (TP) leaf extracts on adenosine monophosphate activated protein kinase (AMPK) level in isolated pancreases. Materials and Methods: In this experimental study, two groups of rats were used as a control group, and diabetic group. In the end of experimental period the animals were sacrificed then pancreas were removed, then isolated rat pancreas was cultured in buffer with or without TP leaf extracts. Measuring the sample glucose level was carried out by spectrophotometric method ( Jenway ,Model 6505 ,UK, Pars Azmmon Co. ,Tehran, IRAN) . Insulin level was assayed by an enzyme immunoassay ELISA kit specific for rats made by Mercodia Rat insulin ELISA ( 10-1250-01,Mercodia AB, Uppsala, Sweden). The adenosine monophosphate activated protein kinase level was determined by ELISA assay method using a rat phosphorylated AMPK ELISA kit ( CSB-E11337r, Cusabio Biotech Co .,LTD).
Results: The results indicate that addition of TP leaf extract significantly increased AMPK level and insulin content compared to untreated group (p<0.05).
Conclusion: These results support the potential of TP leaf extract as a therapeutic modality for diabetes. However, further studies will be necessary to confirm this potential
Ghrelin Administration Increases the Bax/Bcl-2 Gene Expression Ratio in the Heart of Chronic Hypoxic Rats
Purpose: Programmed cell death or apoptosis, is a biochemical procedure that initiates due
to some conditions, including hypoxia. Bax and Bcl-2 are among the agents that regulate
apoptosis. The amplification of the first one triggers the initiation of apoptosis, and the
second one prevents it. Ghrelin is an endogenous peptide that antiapoptosis is its new effect.
The aim of this study is to examine the effect of ghrelin on the Bax/Bcl-2 ratio.
Methods: Twenty four wistar rats were divided randomly in three groups; control, hypoxic
+ saline and hypoxic + ghrelin. Hypoxic animals lived in O2 11% for 2 weeks and received
either saline or ghrelin subcutaneously daily. The bax and Bcl-2 gene expression were
measured by Real-Time RT-PCR.
Results: Chronic hypoxia increased the Bax gene expression significantly compared with
normal animals (P = 0.008), but the Bcl-2 was not affected by hypoxia. The Bax/Bcl-2 ratio
also amplified significantly (P=0.005). Ghrelin administration significantly increased the
Bax/Bcl-2 ratio in the hypoxic animals compared to the hypoxic + saline and normal groups
(p=0.042 and P= 0.001, respectively).
Conclusion: In the present study, animalsā treatment with ghrelin leads to an increment of
Bax/Bcl-2 ratio, which indicates a controversy related to cardioprotection of ghrelin
A Study of arbutin protective effect on cyclosporin A-induced oxidative damage
Background: Cyclosporine A (CsA) is a potent immunosuppressant drug with therapeutic and toxic actions. The use of CsA is limited by its toxicity. Several researchers had proposed that oxidative stress could play an important role in CsA-induced toxicity.Ā ArbutinĀ has recently been shown to possess antioxidative and free radical scavenging abilities.The present study was designed to investigate the in vivoĀ effects of arbutinĀ on lipid peroxidation and antioxidant capacity in the serum of cyclosporine treated rats.
Ā Methods: Adult male Wistar rats were divided into six groups (n=8/group): (I) control (no CsA and arbutin administration), (II and III) were treated subcutaneously (Sc) with arbutin (50,100 mg/kg/bw), respectively, (IV) administered CsA (25 mg/kg/bw)Ā intraperitoneally (IP), (V and VI) received the combination of CsA (25 mg/kg/bw) i.p and arbutinĀ (50,100 mg/kg/bw) Sc daily, respectively. At the end of the treatment (after3 weeks), serum lipid peroxidation was measured by thiobarbituric acid-reacting substances (TBARS) and serum total antioxidant capacity (ferric reducing ability of plasma [FRAP]) was assayed based on spectrophotometric method.
Ā Results: TBARS had been significantly increased by CsA administration compared with control rats. Arbutin (50mg/kg/bw) completely prevented this effect, but arbutin (100 mg/kg/bw) alone or in combination with CsA significantly increased lipid peroxidation compared with controls.
Ā Conclusion: Our data indicate that arbutin (50mg/kg/bw) had protective effect in the CsA-induced toxicity but high concentration of arbutin (100mg/kg/bw) showed meaningful oxidative and lipoperoxidative effects